Diseases, Conditions, Syndromes

HSV-1 prevalence 47.8 percent in 14- to 49-year-olds

(HealthDay)—The prevalence of herpes simplex virus type 1 (HSV-1) and HSV-2 is 47.8 and 11.9 percent, respectively, for individuals aged 14 to 49 years, according to a February data brief published by the U.S. Centers for ...

Diseases, Conditions, Syndromes

Fewer Americans are getting herpes

(HealthDay)— Herpes infection rates are dropping among young Americans, and safer sex practices may be one reason why.

Diseases, Conditions, Syndromes

Untangling how Epstein-Barr virus infects cells

A team led by scientists at Northwestern Medicine has discovered a new epithelial receptor for Epstein-Barr virus, according to a study published recently in Nature Microbiology.

Diseases, Conditions, Syndromes

Adjuvanted shingles subunit vaccine likely more cost-effective

(HealthDay)—The new adjuvanted herpes zoster subunit vaccine (HZ/su) is cost-effective compared with the currently recommended live attenuated herpes zoster vaccine (ZVL), according to a study published online Jan. 2 in ...

Diseases, Conditions, Syndromes

Herpes virus mutant points towards new vaccine strategy

A Northwestern Medicine study published in PLOS Pathogens describes a newly-designed mutant herpes virus called R2 that provides a strategy for the development of novel herpes virus vaccines.

Diseases, Conditions, Syndromes

Shingles vaccine important for older adults

Shingles, also referred to as herpes zoster, is a painful rash that develops as the result of reactivation of the varicella-zoster virus (VZV). VZV is responsible for varicella infection, more commonly known as chicken pox.

page 11 from 32